Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

Population-Based Assessment of the Association Between Magnetic Resonance Imaging Background Parenchymal Enhancement and Future Primary Breast Cancer Risk.

Arasu VA, Miglioretti DL, Sprague BL, Alsheik NH, Buist DSM, Henderson LM, Herschorn SD, Lee JM, Onega T, Rauscher GH, Wernli KJ, Lehman CD, Kerlikowske K.

J Clin Oncol. 2019 Jan 9:JCO1800378. doi: 10.1200/JCO.18.00378. [Epub ahead of print]

PMID:
30625040
2.

Trends in Clinical Breast Density Assessment From the Breast Cancer Surveillance Consortium.

Sprague BL, Kerlikowske K, Bowles EJA, Rauscher GH, Lee CI, Tosteson ANA, Miglioretti DL.

J Natl Cancer Inst. 2019 Jan 8. doi: 10.1093/jnci/djy210. [Epub ahead of print]

PMID:
30624682
3.

Multilevel Examination of Health Disparity: The Role of Policy Implementation in Neighborhood Context, in Patient Resources, and in Healthcare Facilities on Later Stage of Breast Cancer Diagnosis.

Warnecke RB, Campbell RT, Vijayasiri G, Barrett RE, Rauscher GH.

Cancer Epidemiol Biomarkers Prev. 2019 Jan;28(1):59-66. doi: 10.1158/1055-9965.EPI-17-0945. Epub 2018 Oct 23.

PMID:
30352817
4.

The Effect of Digital Breast Tomosynthesis Adoption on Facility-Level Breast Cancer Screening Volume.

Lee CI, Zhu W, Onega TL, Germino J, O'Meara ES, Lehman CD, Henderson LM, Haas JS, Kerlikowske K, Sprague BL, Rauscher GH, Tosteson ANA, Alford-Teaster J, Wernli KJ, Miglioretti DL.

AJR Am J Roentgenol. 2018 Nov;211(5):957-963. doi: 10.2214/AJR.17.19350. Epub 2018 Sep 20.

PMID:
30235000
5.

Breast cancer subtype and survival among Indigenous American women in Peru.

Tamayo LI, Vidaurre T, Navarro Vásquez J, Casavilca S, Aramburu Palomino JI, Calderon M, Abugattas JE, Gomez HL, Castaneda CA, Song S, Cherry D, Rauscher GH, Fejerman L.

PLoS One. 2018 Sep 5;13(9):e0201287. doi: 10.1371/journal.pone.0201287. eCollection 2018.

6.

Association of externalizing religious and spiritual beliefs on stage of colon cancer diagnosis among black and white multicenter urban patient populations.

Polite BN, Cipriano-Steffens TM, Hlubocky FJ, Jean-Pierre P, Cheng Y, Brewer KC, Rauscher GH, Fitchett GA.

Cancer. 2018 Jun 15;124(12):2578-2587. doi: 10.1002/cncr.31351. Epub 2018 Mar 26.

PMID:
29579340
7.

Candidate gene DNA methylation associations with breast cancer characteristics and tumor progression.

Kresovich JK, Gann PH, Erdal S, Chen HY, Argos M, Rauscher GH.

Epigenomics. 2018 Apr 1;10(4):367-378. doi: 10.2217/epi-2017-0119. Epub 2018 Mar 12.

PMID:
29528252
8.

Tumor necrosis in radical prostatectomies with high-grade prostate cancer is associated with multiple poor prognostic features and a high prevalence of residual disease.

Acosta AM, Al Rasheed MRH, Rauscher GH, Vormittag E, Mon KS, Sharif A, Kajdacsy-Balla A, Mohapatra G.

Hum Pathol. 2018 May;75:1-9. doi: 10.1016/j.humpath.2017.11.015. Epub 2017 Nov 24.

PMID:
29180249
9.

Examining racial disparities in colon cancer clinical delay in the Colon Cancer Patterns of Care in Chicago study.

Jones LA, Ferrans CE, Polite BN, Brewer KC, Maker AV, Pauls HA, Rauscher GH.

Ann Epidemiol. 2017 Nov;27(11):731-738.e1. doi: 10.1016/j.annepidem.2017.10.006. Epub 2017 Oct 13.

10.

Performance characteristics of digital vs film screen mammography in community practice.

Dabbous F, Dolecek TA, Friedewald SM, Tossas-Milligan KY, Macarol T, Summerfelt WT, Rauscher GH.

Breast J. 2018 May;24(3):369-372. doi: 10.1111/tbj.12942. Epub 2017 Nov 5.

PMID:
29105900
11.

Absence of an anticipated racial disparity in interval breast cancer within a large health care organization.

Rauscher GH, Dabbous F, Dolecek TA, Friedewald SM, Tossas-Milligan K, Macarol T, Summerfelt WT.

Ann Epidemiol. 2017 Oct;27(10):654-658. doi: 10.1016/j.annepidem.2017.09.002. Epub 2017 Sep 20.

12.

BRCA1 protein expression and subcellular localization in primary breast cancer: Automated digital microscopy analysis of tissue microarrays.

Mahmoud AM, Macias V, Al-Alem U, Deaton RJ, Kadjaksy-Balla A, Gann PH, Rauscher GH.

PLoS One. 2017 Sep 1;12(9):e0184385. doi: 10.1371/journal.pone.0184385. eCollection 2017.

13.

Performance Benchmarks for Screening Breast MR Imaging in Community Practice.

Lee JM, Ichikawa L, Valencia E, Miglioretti DL, Wernli K, Buist DSM, Kerlikowske K, Henderson LM, Sprague BL, Onega T, Rauscher GH, Lehman CD.

Radiology. 2017 Oct;285(1):44-52. doi: 10.1148/radiol.2017162033. Epub 2017 Jun 5.

14.

Negative psychological consequences of breast cancer among recently diagnosed ethnically diverse women.

Tejeda S, Stolley MR, Vijayasiri G, Campbell RT, Estwing Ferrans C, Warnecke RB, Rauscher GH.

Psychooncology. 2017 Dec;26(12):2245-2252. doi: 10.1002/pon.4456. Epub 2017 Jun 16.

PMID:
28499328
15.

Racial disparity in survival from estrogen and progesterone receptor-positive breast cancer: implications for reducing breast cancer mortality disparities.

Rauscher GH, Silva A, Pauls H, Frasor J, Bonini MG, Hoskins K.

Breast Cancer Res Treat. 2017 Jun;163(2):321-330. doi: 10.1007/s10549-017-4166-z. Epub 2017 Mar 1.

16.

National Performance Benchmarks for Modern Diagnostic Digital Mammography: Update from the Breast Cancer Surveillance Consortium.

Sprague BL, Arao RF, Miglioretti DL, Henderson LM, Buist DS, Onega T, Rauscher GH, Lee JM, Tosteson AN, Kerlikowske K, Lehman CD; Breast Cancer Surveillance Consortium.

Radiology. 2017 Apr;283(1):59-69. doi: 10.1148/radiol.2017161519. Epub 2017 Feb 28.

17.

Impact of a False-Positive Screening Mammogram on Subsequent Screening Behavior and Stage at Breast Cancer Diagnosis.

Dabbous FM, Dolecek TA, Berbaum ML, Friedewald SM, Summerfelt WT, Hoskins K, Rauscher GH.

Cancer Epidemiol Biomarkers Prev. 2017 Mar;26(3):397-403. doi: 10.1158/1055-9965.EPI-16-0524. Epub 2017 Feb 9.

18.

National Performance Benchmarks for Modern Screening Digital Mammography: Update from the Breast Cancer Surveillance Consortium.

Lehman CD, Arao RF, Sprague BL, Lee JM, Buist DS, Kerlikowske K, Henderson LM, Onega T, Tosteson AN, Rauscher GH, Miglioretti DL.

Radiology. 2017 Apr;283(1):49-58. doi: 10.1148/radiol.2016161174. Epub 2016 Dec 5.

19.

Breast cancer delay in Latinas: the role of cultural beliefs and acculturation.

Tejeda S, Gallardo RI, Ferrans CE, Rauscher GH.

J Behav Med. 2017 Apr;40(2):343-351. doi: 10.1007/s10865-016-9789-8. Epub 2016 Aug 29.

20.

Mediation of Racial and Ethnic Disparities in Estrogen/Progesterone Receptor-Negative Breast Cancer by Socioeconomic Position and Reproductive Factors.

Rauscher GH, Campbell RT, Wiley EL, Hoskins K, Stolley MR, Warnecke RB.

Am J Epidemiol. 2016 May 15;183(10):884-93. doi: 10.1093/aje/kwv226. Epub 2016 Apr 13.

21.

DNA methylation and hormone receptor status in breast cancer.

Benevolenskaya EV, Islam AB, Ahsan H, Kibriya MG, Jasmine F, Wolff B, Al-Alem U, Wiley E, Kajdacsy-Balla A, Macias V, Rauscher GH.

Clin Epigenetics. 2016 Feb 16;8:17. doi: 10.1186/s13148-016-0184-7. eCollection 2016.

22.

Exploring DNA methylation changes in promoter, intragenic, and intergenic regions as early and late events in breast cancer formation.

Rauscher GH, Kresovich JK, Poulin M, Yan L, Macias V, Mahmoud AM, Al-Alem U, Kajdacsy-Balla A, Wiley EL, Tonetti D, Ehrlich M.

BMC Cancer. 2015 Oct 29;15:816. doi: 10.1186/s12885-015-1777-9.

23.

Racial/Ethnic Disparities in Time to a Breast Cancer Diagnosis: The Mediating Effects of Health Care Facility Factors.

Molina Y, Silva A, Rauscher GH.

Med Care. 2015 Oct;53(10):872-8. doi: 10.1097/MLR.0000000000000417.

24.

Racial and Ethnic Disparity in Symptomatic Breast Cancer Awareness despite a Recent Screen: The Role of Tumor Biology and Mammography Facility Characteristics.

Mortel M, Rauscher GH, Murphy AM, Hoskins K, Warnecke RB.

Cancer Epidemiol Biomarkers Prev. 2015 Oct;24(10):1599-606. doi: 10.1158/1055-9965.EPI-15-0305. Epub 2015 Jul 21.

25.

The effect of neighborhood disadvantage on the racial disparity in ovarian cancer-specific survival in a large hospital-based study in cook county, illinois.

Peterson CE, Rauscher GH, Johnson TP, Kirschner CV, Freels S, Barrett RE, Kim S, Fitzgibbon ML, Joslin CE, Davis FG.

Front Public Health. 2015 Jan 22;3:8. doi: 10.3389/fpubh.2015.00008. eCollection 2015.

26.

Race/ethnicity and disparities in mastectomy practice in the Breast Cancer Care in Chicago study.

Dookeran KA, Silva A, Warnecke RB, Rauscher GH.

Ann Surg Oncol. 2015 Jan;22(1):66-74. doi: 10.1245/s10434-014-3945-6. Epub 2014 Aug 19.

PMID:
25135847
27.

Assessing the quality of race/ethnicity, tumor, and breast cancer treatment information in a non-SEER state registry.

Silva A, Rauscher GH, Ferrans CE, Hoskins K, Rao R.

J Registry Manag. 2014 Spring;41(1):24-30.

PMID:
24893185
28.

Validating self-reported mammography use in vulnerable communities: findings and recommendations.

Allgood KL, Rauscher GH, Whitman S, Vasquez-Jones G, Shah AM.

Cancer Epidemiol Biomarkers Prev. 2014 Aug;23(8):1649-58. doi: 10.1158/1055-9965.EPI-13-1253. Epub 2014 May 23.

29.

The association between neighborhood socioeconomic status and ovarian cancer tumor characteristics.

Peterson CE, Rauscher GH, Johnson TP, Kirschner CV, Barrett RE, Kim S, Fitzgibbon ML, Joslin CE, Davis FG.

Cancer Causes Control. 2014 May;25(5):633-7. doi: 10.1007/s10552-014-0357-7. Epub 2014 Feb 16.

PMID:
24532025
30.

Assessing racial/ethnic disparities in chemotherapy treatment among breast cancer patients in context of changing treatment guidelines.

Silva A, Rauscher GH, Hoskins K, Rao R, Ferrans CE.

Breast Cancer Res Treat. 2013 Dec;142(3):667-72. doi: 10.1007/s10549-013-2759-8. Epub 2013 Nov 22.

31.

Beyond the mammography quality standards act: measuring the quality of breast cancer screening programs.

Rauscher GH, Murphy AM, Orsi JM, Dupuy DM, Grabler PM, Weldon CB.

AJR Am J Roentgenol. 2014 Jan;202(1):145-51. doi: 10.2214/AJR.13.10806. Epub 2013 Nov 21.

32.

Mammogram image quality as a potential contributor to disparities in breast cancer stage at diagnosis: an observational study.

Rauscher GH, Conant EF, Khan JA, Berbaum ML.

BMC Cancer. 2013 Apr 26;13:208. doi: 10.1186/1471-2407-13-208.

33.

Potentially missed detection with screening mammography: does the quality of radiologist's interpretation vary by patient socioeconomic advantage/disadvantage?

Rauscher GH, Khan JA, Berbaum ML, Conant EF.

Ann Epidemiol. 2013 Apr;23(4):210-4. doi: 10.1016/j.annepidem.2013.01.006. Epub 2013 Mar 1.

34.

Disparities in screening mammography services by race/ethnicity and health insurance.

Rauscher GH, Allgood KL, Whitman S, Conant E.

J Womens Health (Larchmt). 2012 Feb;21(2):154-60. doi: 10.1089/jwh.2010.2415. Epub 2011 Sep 23.

35.

The import of trust in regular providers to trust in cancer physicians among white, African American, and Hispanic breast cancer patients.

Kaiser K, Rauscher GH, Jacobs EA, Strenski TA, Ferrans CE, Warnecke RB.

J Gen Intern Med. 2011 Jan;26(1):51-7. doi: 10.1007/s11606-010-1489-4. Epub 2010 Sep 1.

36.

Misconceptions about breast lumps and delayed medical presentation in urban breast cancer patients.

Rauscher GH, Ferrans CE, Kaiser K, Campbell RT, Calhoun EE, Warnecke RB.

Cancer Epidemiol Biomarkers Prev. 2010 Mar;19(3):640-7. doi: 10.1158/1055-9965.EPI-09-0997. Epub 2010 Mar 3.

37.

Comparing the reliability of responses to telephone-administered versus self-administered Web-based surveys in a case-control study of adult malignant brain cancer.

Rankin KM, Rauscher GH, McCarthy B, Erdal S, Lada P, Il'yasova D, Davis F.

Cancer Epidemiol Biomarkers Prev. 2008 Oct;17(10):2639-46. doi: 10.1158/1055-9965.EPI-08-0304.

38.

Challenges for multilevel health disparities research in a transdisciplinary environment.

Holmes JH, Lehman A, Hade E, Ferketich AK, Gehlert S, Rauscher GH, Abrams J, Bird CE.

Am J Prev Med. 2008 Aug;35(2 Suppl):S182-92. doi: 10.1016/j.amepre.2008.05.019.

39.

Accuracy of self-reported cancer-screening histories: a meta-analysis.

Rauscher GH, Johnson TP, Cho YI, Walk JA.

Cancer Epidemiol Biomarkers Prev. 2008 Apr;17(4):748-57. doi: 10.1158/1055-9965.EPI-07-2629. Epub 2008 Apr 1. Review.

40.

Biomarkers of Psychological Stress in Health Disparities Research.

Djuric Z, Bird CE, Furumoto-Dawson A, Rauscher GH, Ruffin MT 4th, Stowe RP, Tucker KL, Masi CM.

Open Biomark J. 2008 Jan 1;1:7-19.

41.
42.

Occupation, hobbies, and acute leukemia in adults.

Terry PD, Shore DL, Rauscher GH, Sandler DP.

Leuk Res. 2005 Oct;29(10):1117-30. Epub 2005 Apr 1.

PMID:
16111530
43.

Baseline predictors of initiation vs. maintenance of regular mammography use among rural women.

Rauscher GH, Hawley ST, Earp JA.

Prev Med. 2005 Jun;40(6):822-30.

PMID:
15850884
44.

Validating cancer histories in deceased relatives.

Rauscher GH, Sandler DP.

Epidemiology. 2005 Mar;16(2):262-5.

PMID:
15703544
45.

Alcohol intake and incidence of de novo adult acute leukemia.

Rauscher GH, Shore D, Sandler DP.

Leuk Res. 2004 Dec;28(12):1263-5.

PMID:
15475066
46.

Hair dye use and risk of adult acute leukemia.

Rauscher GH, Shore D, Sandler DP.

Am J Epidemiol. 2004 Jul 1;160(1):19-25.

PMID:
15229113
47.
48.

Is family history of breast cancer a marker of susceptibility to exposures in the incidence of de novo adult acute leukemia?

Rauscher GH, Sandler DP, Poole C, Pankow J, Shore D, Bloomfield CD, Olshan AF.

Cancer Epidemiol Biomarkers Prev. 2003 Apr;12(4):289-94.

49.

Family history of cancer and incidence of acute leukemia in adults.

Rauscher GH, Sandler DP, Poole C, Pankow J, Mitchell B, Bloomfield CD, Olshan AF.

Am J Epidemiol. 2002 Sep 15;156(6):517-26.

PMID:
12225999
50.

How consistently do women report lifetime mammograms at successive interviews?

Rauscher GH, O'Malley MS, Earp JA.

Am J Prev Med. 2002 Jan;22(1):8-14.

PMID:
11777673

Supplemental Content

Loading ...
Support Center